Pallidotomy is a medical procedure. It involves creating a small lesion in a specific part of the brain called the globus pallidus. This is done to help manage symptoms of conditions like Parkinson's disease.
Every report comes from a Lived member, sent anonymously.
Have you had Pallidotomy for Parkinson's Disease?
Pallidotomy is a brain procedure that makes a small, permanent, precisely placed lesion in the globus pallidus interna, a deep brain region involved in controlling movement. In Parkinson's disease this region becomes overactive, and the lesion quiets it. The procedure is usually done on one side of the brain, and its benefit appears on the opposite side of the body, so the team treats the side opposite your most affected arm and leg. It is mainly considered for advanced Parkinson's disease when medicine no longer gives smooth control. That usually means dyskinesia (involuntary twisting or jerking movements caused by long-term treatment with levodopa, the main Parkinson's medicine) or troublesome off periods, when a dose wears off and stiffness, slowness or tremor return. Pallidotomy treats these movement symptoms; it does not stop Parkinson's from progressing, and most people continue their medicine afterward. It has also been used for severe dystonia, a disorder of sustained muscle contractions, mainly in people who cannot have other surgery. There are two ways to make the lesion. Radiofrequency pallidotomy passes a thin probe through a small hole in the skull and heats its tip. Focused ultrasound pallidotomy aims many ultrasound beams through the intact skull under magnetic resonance imaging (MRI) guidance, with no incision. In the US, the focused ultrasound version is approved by the Food and Drug Administration (FDA) for one side of the brain in adults 30 and older with advanced Parkinson's whose movement complications are not controlled by medicine, used alongside that medicine. The main alternative is deep brain stimulation (DBS), in which electrodes are implanted and connected to a battery-powered device under the skin. DBS can be adjusted over time and switched off, while a lesion is permanent. Pallidotomy avoids implanted hardware and battery changes, which matters for some people. It is usually not suitable for people with significant memory or thinking decline, existing speech or swallowing difficulty, frequent falls or balance problems, or a bleeding disorder.
Evaluation usually involves a movement disorder neurologist and a neurosurgeon, who confirm that symptoms come from Parkinson's, judge whether dyskinesia or off periods are the main problem, and check thinking, speech and swallowing. MRI scans map the target. For focused ultrasound, a computed tomography (CT) scan also measures the skull, because some skulls do not let enough ultrasound energy through; you also need to be able to have an MRI, so pacemakers and some other implants can rule it out. Tell the team early if you take aspirin, warfarin, clopidogrel or any other medicine that thins the blood, including anti-inflammatory painkillers such as ibuprofen. These raise the risk of bleeding in the brain, and the team will tell you whether and when to stop them. You may be asked to skip some Parkinson's medicine doses before the procedure so your symptoms are visible while the team tests the target. Bring your usual medicines to the hospital, and arrange for someone to take you home. For radiofrequency surgery, a small patch of hair may be shaved and some centers ask you to wash with an antiseptic lotion for several days beforehand. Focused ultrasound requires shaving the whole head.
Most people are awake for pallidotomy. Being awake lets the team check your movement, speech and vision as they test the target, before making the permanent lesion. A rigid frame is fixed to the head with pins after the skin is numbed with local anesthetic, which holds the head still and gives precise coordinates. Some centers perform radiofrequency pallidotomy under general anesthesia instead. In radiofrequency pallidotomy, the surgeon makes a small cut in the scalp under local anesthetic, drills a small hole in the skull and guides a probe to the target. A small electrical current tests the position, then the probe tip is heated to create the lesion. The wound is closed with stitches or staples. The whole procedure often takes two to three hours. In focused ultrasound pallidotomy, you lie in an MRI scanner with your head inside a helmet-shaped device filled with cooled water. Low-energy pulses first warm the target slightly without damaging it, so the team can confirm the position and watch for side effects, then stronger pulses create the lesion. Treatment averages about two hours. Headache, a sense of heat or pressure, dizziness and nausea are common during treatment and usually ease once it ends.
After radiofrequency pallidotomy, most people stay in hospital for one to three days. After focused ultrasound, people are often observed for a few hours and go home the same day or the next. Dyskinesia may settle right away, but early results vary, and the goal is lasting benefit over the following weeks. In the main trial, benefit was judged at three months, and follow-up visits review how symptoms have responded. In the first weeks, swelling around the lesion can cause temporary problems such as unsteady walking, slurred speech, facial weakness or confusion, which often fade as the swelling settles. Contact the surgical team promptly if any of these problems is new, getting worse or not settling as expected, since that can signal bleeding or worsening swelling rather than normal recovery. Parkinson's medicine is usually continued, and the neurologist may adjust doses as dyskinesia changes. After radiofrequency surgery, keep the wound clean and dry and avoid touching it; stitches or staples usually come out after seven to ten days. Infection can appear a week or more after surgery, so redness, swelling or discharge from the wound should be reported to the surgical team. Ask the team when you can drive and return to strenuous activity or heavy lifting; some centers wait until a follow-up visit confirms recovery. Follow-up visits also check whether any side effects remain.
The most important risks come from the lesion itself or from bleeding. A lesion placed slightly off target, or swelling around it, can affect nearby pathways for speech, movement, vision and taste. In the main sham-controlled trial of focused ultrasound pallidotomy, side effects included slurred speech, walking difficulty, loss of taste, visual disturbance and facial weakness. Most such problems improve, but some are permanent, and because a lesion cannot be switched off like a stimulator, a lasting side effect cannot be adjusted away. Changes in behavior or swallowing have also been reported, and thinking problems were reported more often after radiofrequency surgery than after focused ultrasound. Radiofrequency pallidotomy carries a small risk of bleeding in the brain. Most bleeds cause no symptoms, but a large one can cause a stroke, paralysis or death; one specialist center puts major complications like this at under 1 in 100. Wound infection is also uncommon. Focused ultrasound avoids an incision but can cause scalp discomfort, headache during treatment and, rarely, scalp burns. The benefit is not guaranteed. In the sham-controlled trial, about 7 in 10 people had a meaningful reduction in dyskinesia or in off-medication movement symptoms on the treated side at three months, compared with about 3 in 10 after a sham procedure (a simulated treatment that made no lesion), and most who improved still did at one year. A systematic review found that some people get too little benefit, which happened somewhat more often after focused ultrasound than radiofrequency, although data are limited. Treating both sides of the brain is less common, and its safety is debated.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience with Pallidotomy, what to expect, or ask the community a question.